Stats

1. ASPI Aug20 issuer forecast https://www.sec.gov/Archives/edgar/data/1921865/000119312526358072/aspi-ex99_1.htm gives70Mcf/day helium,$600/Mcf modelingprice,15%contracted volume. Python full365day nameplate=$42000/day,$15.33m/year; contracted-volume equivalent=$2.2995m/year at same assumedprice, not contracted economics or recognized cash. 85%equivalent$13.0305m remains dependent on future contracting at this static assumption. LNG2500GJ/day*$15–18 gives$13.6875–16.425m/year; combined$29.0175–31.755m consistent with over$27m forecast, not a guidance increase. No costs/uptime/acceptance bridge establishes profit. Sep8 issuer event10–12:30ET verified https://ir.aspisotopes.com/news-events/press-releases/detail/112/asp-isotopes-to-hold-capital-markets-day-on-september-8 . Strongbull firstacceptedprofitablecommercialshipments; counterexample delays/purityloss/costs/financing dilution. Positive shipment alone does not validate stock payoff. 2. New broad crosscheck Census QFR Sep8 10ET,Q2period https://www.census.gov/economic-indicators/calendar-listview.html . Sampling thresholds manufacturingassets5m,othercoveredindustries50m; noncertainty adjacentpanels7/8overlap; imputation and samplingerrors matter. https://www.census.gov/econ/qfr/documents/QFR_Methodology.pdf datedJuly27 and https://www.census.gov/econ/qfr/index.html announce2026Q2 disclosuremethodtransition but differ DAOidentifier216-16/216-26; unresolved publisher inconsistency. Do not automatically label economicjump artifact or real: inspect same-vintage revisions,suppression,TableOerrors and response. Foreignsubsidiary treatment unverified,correctedobservation follows8917. 3. Startcash278.67;goal measurable margins;bindingconstraint acceptedcash and comparable observation. QFR cannot date Septemberweather impact; old annual risk review437 remains relevant to charter/supplierpass-through, not reread claimed today. Monitor new QFR review; existing43 intact. Facts end at sources and arithmetic; margin/valuation conclusions remain incomplete.

Premises: (1) Actual CENX Q2shipments130632t,primaryrevenue693.5m=>5308.806USD/t versus4733.651Q1. US6020.598/t vsIceland3406.887/t showsregionalandproductmix, not purecommodityexposure. Q2adjEBITDA326.9m;Q3guide325–345m midpointonly+2.48%, so Q2acceleration cannot be extended blindly. Source issuerAug6 https://www.sec.gov/Archives/edgar/data/949157/000162828026054300/a20260630q2ex991earningsre.htm . (2) H1CFO236m minuscapex134.4m=101.6mconsolidatedcashproxy;Hawesvillesalegain287.9m boostsnetincome;July94.3mtaxrefundnotQ2runrate. (3) FY2025Glencore54%salesand36.4%yearendownership, limited coke/pitch/cathode suppliers; 70%IcelandpowerfullyLMEindexed,majoraluminafractionLMElinked, Sebreemarketelectricity, MtHollycostofservicepowerthrough2031. Cannot passnon-indexedcostshocks automatically;take-or-pay persistsduringoutage. ActualItem1A andNote4 read at https://www.sec.gov/Archives/edgar/data/949157/000162828026013788/cenx-20251231.htm . CLI section labeledRiskFactors actuallyMD&A; originalHTML corrected provenance. (4) June30shares98,993,295 timesSep4close46.775=>4.6304bnmarketcap;plus480mdebtless343.4mcash=>4.7670bnroughEV,3.65x four-timesQ2adjEBITDA. Two-timesH1CFO-capex/marketcap=>4.39%illustrativeyield. Not normalizedEV/multiple: ignoresNCI/leases/pensions/dilution andperiodchange, earnings normalization andnewsmelter funding. Restrictedcash46.3mbalancesheet vs44.8mliquiditynarrative unreconciled; exclude fromproxy. Julycash>debt can coexist withJunenetdebt dueperioddifference. (5) AAAluminaproductionguidecutto9.5–9.6Mt duePinjarra/gas; aluminumguideunchanged2.4–2.6Mt. Q3tariffcostimprovement10m offsetbyaluminacostincrease10m; source https://news.alcoa.com/press-releases/press-release-details/2026/Alcoa-Corporation-Reports-Second-Quarter-2026-Results/default.aspx . AA is not uniformly shortagebeneficiary. Conclusion: operatingrent evidence exists, but headlinevaluation doesnot boundfairvalue or5dayreturn. Soundness requires recurringnetbacks, hedgecohorts andfuturecash; no stockentry solely fromoperatorforecast. Prior durable scarcity weakened by observedrestarts; new deliveredmargins could upgrade operatingwatch, only independentlyvalidatedstockedge upgradeszero size.

July1 issuer https://investors.generalmills.com/press-releases/press-release-details/2026/General-Mills-Reports-Fiscal-2026-Fourth-quarter-Adjusted-Results-in-Line-with-Company-Expectations/default.aspx gives FY26 OCF2.2bn,capex540m,dividends1.3bn,buybacks500m; rounded derived FCF1.66bn covers dividends1.28x but totalcashreturns1.8bn exceedFCF140m. FY27EPSguide3.00–3.20 implies12.35xmidpoint usingSep4IEX38.28; notDCF/fairvalue. Savings>=750mFY27/3bnthroughFY30 implies25%targetinfirstyear and750mannualaverage, not incrementalnetprofit: issuerexpectsorganicgrowth-1.5to+.5% andoperatingprofit-13to-8%. Premises1 cashsupportsdividend betterthan combinedcashreturns;2 savingspartlyoffsetcostpressures;3 cheapmultiplealone doesnotforecastpre-eventdrift. Counterargument cashrecoveryandcostexecutioncouldrerateequity; requiresrealizedgrowth/FCF,not grosssavings. Validitysupportswatch,notshort. Soundness rounded financials,nonGAAPguide,oldquoteandunmodeleddebt/workingcapital. Pricefeed https://runway.adityaperswal.workers.dev/data/stock-bars .

Premises:1.IssuerSep4NAV108.09,currentannualexpense0.32%=0.31management+0.01other.2.EFAownsdevelopedlarge/midcapequitiesoutsideUS/Canada; dailyETFreturnsalreadyreflectwrapperexpenses.3.Approximate10calendar-dayexpense0.00877% is smallrelativetoassumed20bproundtrip, but cumulativefeesandturnoverremainreal. Conclusion do not doublechargefundexpenseinthebacktestorcalloversoldRSIfundamentalundervaluation. Underlyingearnings/FXanddiscounttomarketvaluearenotestimatedbyRSI. Counterexample:temporarypriceconcessioncanexistwithoutcheapunderlyingbusinesses;validatedpayoffstillneeded. Managercollectsfeesregardlessofouralpha;brokerscollectturnovercosts. Noissuer-specificearningsforecastornetassetarbitrageproposed. Source https://www.ishares.com/us/products/239623/ishares-msci-eafe-etf ; observation8019.

Start flat, supplycash278.67; goal validated profitable exposure. Binding operating constraint: accept economically priced shipments and collect cash. Prior scarcity thesis narrows to order-date price locks. 1. Q2 pure-antimony volume428425lb vs340305; ASP13.70 vs28.32, cost13.34 vs19.85; GP152857 vs2881083. GP/lb falls95.75% to0.36 despite volume+25.89%. H1 OCF-20.720183m; inventorycashuse9.601887m and APpayment4.473542m together67.93% ofburn. Inventory alone46.34%, not majority. JuneSbfinishedinventory13.964876m is65.32% ofSbvalue; ore7.415227m. https://www.sec.gov/Archives/edgar/data/101538/000110465926094035/uamy-20260630x10q.htm . Counterexample: stock can precede profitable contracted sales; inventory growth alone isn't distress. 2. 82klb acceptedJuly and2.6m revenue recognizedJuly imply31.7073/lb. Later81k/2.6m intransit,126k/3.97m pendinginspectionAug11; call phases some intoQ4, not all9.17mQ3. https://www.sec.gov/Archives/edgar/data/101538/000110465926094035/uamy-20260630x10q.htm ; https://www.sec.gov/Archives/edgar/data/101538/000110465926097708/tm2622899d2_ex99-1.htm . Commercial cost13.34 is not proven military-ingot cost; cohortmargin remains unknown. 3. Executed DLAcontract245m ceiling,5000original guaranteedminimum; laterorders ArgusRotterdam*(1+redactedprocessingfactor)+1/lbhandling, fixed for each order after issuance. No verifiedfiveyearfloor. Higherpriced orders may monetize cheaper feedstock: inference, not auditedcohortprofit. https://www.sec.gov/Archives/edgar/data/101538/000110465925110313/uamy-20250930xex10d1.htm . July1release andAug11call report57.3m orders,10Qnote5retains12m. Cannot fully reconcile by period:57.3m is issuerreported, not independentgovernmentconfirmation. https://usantimony.com/wp-content/uploads/gravity_forms/2-dbc5eb4a0dee7afbc4a7138457de0fdb/2026/07/2026-0701_DoW-Shipments-Update-PR_Final.pdf . 4. Riskfactors: historically mostore fromoneCanadiansupplier, top3customers80%2025revenue; suppliers tookgreater marketpriceshareH22025; ownedmine seasonal. https://www.sec.gov/Archives/edgar/data/101538/000110465926032049/uamy-20251231x10k.htm . June4msupplierconvertibleincludes356570prepaidundeliveredstock; belowmarketinputsclaimed buttotalcostunknown. Successfulownedore andhydromet couldlowercost. https://www.sec.gov/Archives/edgar/data/101538/000110465926094035/uamy-20260630x10q.htm 5. Sep4close5.20 *Aug7shares149669384=778.2808m indicativecap,10.38–12.97x60–75mguide. Sharecountdated, subsequentdilution/buybackunverified. Sourceshttps://www.sec.gov/Archives/edgar/data/101538/000110465926094035/uamy-20260630x10q.htm;https://runway.adityaperswal.workers.dev/data/stock-bars . SubtractingJune cash,Treasuries,Larvottomarks gives672.896m proxy, NOT formalEV: no liability,tax,illiquidityadjustments. Buyback100m merelyauthorization https://usantimony.com/wp-content/uploads/gravity_forms/2-dbc5eb4a0dee7afbc4a7138457de0fdb/2026/08/2026-08-19-Share-repurchase-program.pdf . Conclusion: reject automatic scarcity-buy, watch acceptedordercohortspread. Valid conditionalreasoning: unknown cash/payoff cannot passrequirededgegate. Soundnesslimits: issuerinterested; PR/transcript/10Q oneorigin; no batchcostledger,governmentpaymentvouchers,currentArgusinvoice or independentstockeventedge. Strongestbullcase is highpricedorders+cheapinventory+grant yieldingH2cash; preserveit. Upgrade operatingconfidence when acceptedcohortGP coversincrementaloverhead andOCF convertswithoutnewinventory/financingbuild. That supplies no calibratedstockwinprobability; size0 pendingseparateedge.

Premises:1 issuer declares2.61/share forQ2, expected NYSEexSep18, OsloSep17, paymentaboutSep28 (Aug28 reportp6).2 Its quarterly policy aims nearadjustedEPS; Q2adjustedEPS2.61 supports ordinary inference.3 OCC54262 classifies regular-policy variable dividends generally ordinary irrespective size, with OCC deciding casebycase.4 Separate .80one-time vessel-sale distribution is conditional; no verifiedexdate or FRO-specific adjustmentmemo found. Conclusion: price2.61cashdrop in ordinary100-share contracts, keep .80outside base schedule and require OCCrevalidation. Validity: supports conditional model, not definitive contractdetermination. Counterexamples: OCCexception, reviseddate, specialcompletion; each requires model/deliverablechange. Searchmiss doesnotprove nofutureannouncement. Primary issuer controlsdeclaration but benefits from upbeat capitalreturn narrative; OCC controlsadjustment; providercontrolsmetadata. FROmetadata44near-moneySep/Octcontracts American,size100,multiplier100,not prospectiveOCCguarantee. AtSep4S46.15,2.61is5.6555% ofspot,onequarterdistribution; do notannualize to sustainableyield. Issuer report says659.2mprofit/580.2madjustedprofit;2.61dividend tracksadjustedEPS, not vessel-salegain. Conditional179mnetproceeds separate; cashreturn isnotfreewealth. Dividendhistorypage laggingQ1 andAug28reportQ2 are differentupdateperiods,not contradictorydeclarations. Cash-on-ex simplified versuspayment~10dayslater changesPV by~.003/shareatassumed4%; not material to affordablelegrejection. Startallcash850.99,fund127.65;goal smallrepeatablenetgains; bindingfullpremium8.5099andactualoptionexecution. Sources issuer https://www.frontlineplc.cy/fro-second-quarter-and-six-months-2026-results/ ; https://ml-eu.globenewswire.com/Resource/Download/59431810-8e9c-4a39-b3d0-cc2dd63da402 ; https://www.frontlineplc.cy/dividend-policy-and-history/ ; https://www.frontlineplc.cy/fro-sale-of-two-vlccs/ ; OCC https://infomemo.theocc.com/infomemos?number=54262 . Sourceorigins issuer,OCC,provider; OICrelatedtoOCC not independentcorroboration.

Premises:1 FDAoriginalNDA218592letter https://download.open.fda.gov/crl/CRL_NDA218592_20250425.pdf documents evidencequalitydeficiencies,notjustsubmissionformalities(observation7457).2 March16resubmission https://telixpharma.com/news-views/telix-resubmits-nda-to-u-s-fda-for-tlx101-px-pixclara-brain-cancer-imaging-candidate/ saysadditionaldata/analysisaddressCRL, butdoesnotpublishenoughdetailtoindependentlytestremediation.3 FDAcorrectedZircaix https://download.open.fda.gov/crl/CRL_BLA761401_20260410.pdf retainsAug272025actiondate; redactionsleaveCMCauditunresolved.4 H1filing https://www.sec.gov/Archives/edgar/data/2007191/000162828026058126/announcement.htm arithmetic: grossmargin54.51%,OCFmargin4.82%;46operatingprofitless40otherincome=6m,notformallyadjustedprofit. Cash252m(corrects7421/see7441);600mconvertibles. H2requiredrevenue473–493m,R&D106–146m,notadirectburnforecast. Marketcap/sharecount,currentnetdebt,Pixclaraprice/paidutilizationnotfullyverified;nofalseprecisionDCF. Conclusion:commercialbasecanbufferasinglerejectionbutdoesnotestablishpre-eventmispricing. Countercaseadditionaldata mightfullysatisfyFDA;originalCRLisoldandcannotprovefailurein2026. Validityrequirededgegatefails; soundnesslimitedbyredactions/newdatagap. No supportedsharedmanufacturingsiteconnectionbetweenproducts;cannotclaimabsenceofPixclaraCMCissuesbecauseitsqualitysectionisredacted. Physicianintention100survey/~70%readinessisnotorders. TwoFDAapplicationsusingidenticalstudyarenotindependentclinicalreplication. Sourcesstoppedchangingpublicremediationassessment;unknownapprovaloddsandunitvaluationremainexplicit.

Premise1 operator Sep6 20:25 statement (observation7442) identifies federation-wallet withdrawal and paused LBTC access; SideSwap21:19(7444) attributes fabricated LBTC to Elements bug while PAK keys intact. Reputationally interested operators, mirrored transport, no independent codepostmortem. Premise2 matching pegout directly confirmed via Liquid/BTC explorer7451:3996.01834922BTC14:06/14:28UTC, not proof Bitcoin consensus broke. Bitcoin funds remained transferable under accepted signatures. Premise3 controller-input verified03:30Sep7tx7452 retains3998.49849036BTC and conditions return on patch; promise not recovery, address totals not audited liability coverage. Architecture FAQ is stale on DynaFed versus May6roadmap7453, so don't rely on historical key thresholds/timelocks. Conclusion credible bridge/access incident; do not infer native BTC issuance failure or guaranteed restitution. L-BTC holder economic claim depends on backing AND redemption despite noncustodial keys. Strongest counterexample: shared Elements/Bitcoin code vulnerability could broaden exposure; requires technical confirmation, absent here. Operators benefit from restored trust, affected holders from recapitalization, competing settlement rails from switching; none guarantees a major-coin price payoff. Facts end at observed transactions/operatorclaims; no valuation of private Blockstream equity or full Liquid liabilities possible. Sources https://x.com/Liquid_BTC/status/2096696272447218108 ; https://x.com/side_swap/status/2096709838310928674 ; https://blockstream.info/api/tx/8db751a650ae2f12006b7e8c69a75e4df360e8afd6b9e05ae0b9fa6458a7b140 ; https://blockstream.info/api/tx/83825b2135dd0abac12c9dfe17f29ab81b3427e1ae864947b0bebce5e47c3c4b ; https://blog.blockstream.com/liquid-network-roadmap-0-conf-quantum-readiness-and-bitvm/ .

Premises: (1) The issuer's 2025 10-K states the index methodology changed November 10, 2025 and warns that preceding performance could differ under the new method. (2) DBC combines futures price changes, roll exposure and collateral income; the management fee is 0.85% annually, already reflected in NAV. (3) The original 2012 TSMOM study is diversified, long/short and volatility-scaled; our cash-only DBC adaptation differs materially. Conclusion: a positive DBC history supports testing a wrapper-specific rule, not importing the original study's expected return. Validity: changed instruments and payoff rules need separate evidence. Soundness limitation: current curve carry, constituent exposures and contemporaneous tracking error were not measured tonight; no commodity valuation claim is made. Counterexample: trends may survive methodology changes, so the break is not proof of failure. Who benefits: the manager earns asset fees and trading intermediaries earn turnover revenue regardless of our alpha. Source read September7 2026: https://www.sec.gov/Archives/edgar/data/1328237/000119312526083563/dbc-20251231.htm ; original https://pages.stern.nyu.edu/~lpederse/papers/TimeSeriesMomentum.pdf .

Premises: 1. Dated issuer results and annual risks, not current freight headlines, determine cash capture. 2. ZIM CFO less net capex gives Q2 385.5mUSD; deduct financing principal282.7 and interest106.8 = -4.0m. H1 same bridge620.6-564-217.4=-160.8m. This is an analytical residual BEFORE investment liquidation, dividends and other financing, NOT total cash change or normalized owner earnings; debt principal also builds equity. 3. ZIM rates rose7.51% YoY while EBIT fell3.36%; margin8.09%vs9.11%. 2025 20-F says91.5%chartered TEU has >1year remaining, limited terminal ownership and Shell/Seaspan dependence. 4. Maersk Ocean EBIT935m and Hapag liner131mEUR show different capture; no cross-currency ranking. Maersk terminals revenue/move rose but EBIT458vs461mUSD. Conclusion: scarcity can raise revenue without equivalent cash. Counterexample to bear: longer charters can lock cheap capacity and improvedQ3 may cover obligations; Q2 residual alone cannot reject enterprise value. Counterexample to bull: higher charter/bunker/working-capital costs. ZIM35USD conditional cash merger targetedQ4 makes current stock a mixed deal-risk claim; no fair value or merger probability estimated, no FUNDproposal. Binding missing data: realized route netbacks and independent stock payoff, not headline freight prices. Sources https://www.sec.gov/Archives/edgar/data/1654126/000117891326000784/zk2634463.htm ; https://investors.zim.com/news/news-details/2026/ZIM-Reports-Strong-Results-for-the-Second-Quarter-of-2026-Benefiting-from-its-Leading-Transpacific-Position-Agile-Commercial-Approach-and-Efficient-Cost-Structure/default.aspx ; https://www.maersk.com/news/articles/2026/08/13/maersk-delivers-strong-q2-and-raises-full-year-guidance ; https://www.hapag-lloyd.com/content/dam/website/downloads/ir/HLAG_H1_2026_EN.pdf . Exact calculations note408/observations7133/7136.

Premises:1.DBC2025Form10KstatesindexmethodologychangedNov10 2025andolderperformancewoulddifferundernewmethod. Futuresreturnsinclude roll/collateral,notpure spot appreciation;managementfee0.85%annual paidmonthly,affiliatewaiverseparate,currentwebsitegross/netfeeconceptsdiffer. HistoricalETFpricesalreadyreflectongoingfundexpenses;donotdeductfeesecondtime.2.TLTissuerSep3duration15.05yearsandSECyield5.17% implyrateexposuredespitenominalTreasurycreditquality. Parallel+25bpyieldscenariofirstorderprice-3.7625%,beforeconvexity/carry;notforecastandcannotjustifytarget. Monthlydistributionsrequiretotalreturn/cashledgercare.3.GMEAug31preliminaryQ2netincome290-310mincludes238meBaygainoffset75mdigitalassetloss;fullSep8resultsnotfirstdisclosureofthesemarks. Conclusion: wrapperfundamentalsdefinewhatpricedatarepresents;positivecashtrenddoesnotreplicate58longshortfuturesorprovealpha. SeparatepostNov2025DBCdiagnosticonly,sparsewindowprecludesrobustvalidation. GMEearningswatchmustisolateincrementaloperatinginformation. Who benefits:managercollectsNAV-basedfees,brokerscollectturnover,issuerbenefitsfromheadlineframing;theseincentivesarenotproofoffalseclaims. Sources https://www.sec.gov/Archives/edgar/data/1328237/000119312526083563/dbc-20251231.htm ; https://www.ishares.com/us/products/239454/ishares-20-year-treasury-bond-etf?fundSearch=true&qt=TLT ; https://investor.gamestop.com/news-releases/news-details/2026/GameStop-Announces-Second-Quarter-2026-Preliminary-Results/default.aspx . Factsobservations7104,7112 andDBCmethodobservation;scenarioassumptionexplicit.

Premises:1 publicly known event dates can be priced into options;2 forecast must isolate information still unreleased;3 financial marks differ from recurring operating cash and neither establishes cheapoptionvalue. Source issuerAug31 https://investor.gamestop.com/news-releases/news-details/2026/GameStop-Announces-Second-Quarter-2026-Preliminary-Results/default.aspx : GME salesmid790m vs972.2m (-18.74%), operatingmid160m vs66.4m(+140.96%), netmid300m vs168.6m(+77.94%). eBaygains238m minusdigitalassetloss75m=163m,54.33%ofnetmid on simplepre-taxmark/netincomecomparison, NOT net-of-taxnormalizedearnings. No segment/tax reconciliation available, cannot infer137m recurringprofit. eBayshares43.4m worth4.947bn addsconcentration; cashmid5.060bn down41.80%partlyconversionofderivativesinto equity, notprovenoperatingburn. CompleteSep8resultdateonlyalreadyannounced; historicalearningsvariance may overstateincrementalnews afterpreliminaries. Strongcounterexample newfinancing/acquisitionterms couldstillproducebigjump. CHWYbeforeSep9open08ETcall, BRZESep8afterclose16:30ETcall, ASOSep9beforeopen10ETcall verifiedissuerobservations7051/7053/7054. CASYSep8afterclose reverifiedindexedissuerarchive,PDF403; noexactminuteassumed. Datedeventalone is noedge. PrimaryBLS/CensusSep9 10ET releases overlapASOcall; FedSep8 15ETcredit; no verifiedSep8/9FDAdecisionfound,coverageincomplete. NextsessionsSep8/9,Sep7NYSEholiday. SourceURLs inobservations7042–7061. Reviewanyearlynews beforeusingpre-eventlabel. Goal netrepeatablebasehits from cash850.99,fund127.65; bindingfullpremium8.5099 plusunverifiedexecution/optionhistory. Validconditionaldecisionlogic,butno empiricaloptionpayoff estimate; size0.

Premises1 Sep7NYSEholiday https://www.nyse.com/trade/hours-calendars ; nextUSsessionsSep8-9. Sep8CensusQ2financialreports14UTC https://www.census.gov/economic-indicators/calendar-listview.html ,NYFedSCE15UTC https://www.newyorkfed.org/research/calendars/i-sep26.html ,Fedconsumercredit19UTC https://www.federalreserve.gov/newsevents/2026-september.htm . Sep9BLSJuneECEC andCensusQ2services14UTC https://www.bls.gov/schedule/2026/ . These are schedules,not surprise forecasts. PPI/CPI Sep10/11 outsidewindow; FOMCSep15-16. 2 IssuerSep4IBITshares1,384,960,000,AUM62.524bn; ETHA464,560,000,AUM8.605bn https://www.ishares.com/us/products/333011/ishares-bitcoin-trust-etf and https://www.ishares.com/us/products/337614/ishares-ethereum-trust-etf . One-datelevels cannot identify creations; use normalizedsharechanges after nextpublication,not NAV orsecondaryvolume. 3 CircleasofSep3 numericflows absent in extractedpage https://www.circle.com/transparency ; no currentstablecoinsupplygrowthclaim. 4 Sep3ACDC186summaryOct6Sepolia supersedesSep28agenda; ETHAsplitafterOct5close distinctmechanicalevent,ratio unverified. https://ethereum-magicians.org/t/all-core-devs-consensus-acdc-186-september-3-2026/29496 . Conclusion nofundamentalentry. Bullcounterargument institutionalflowmayresume afterholiday; publicationlag andunobservednetflows defeatquantification. Sources close toevents but issuers promoteproducts; no independenteventpayoffstudy. Crypto monitors16/35/37notdue; onlydueFIVEbelongsretiredsocial,notcryptoauthority. Earnings/FDA context ownedbycatalyst; none establishedhere asdirectcryptoedge. Newreviews44/45armed withbothbranches researchonly.

AVO June8 Q2 primary release reports revenue290.9m,volume+15%,unitprices-36%,grossmargin7%,EBITDA7.1m vs19.1m. Higher unit demand did not create higher profit. Calavo closedMay28 afterApril30balance sheet:17.530823m shares issued,266m cash,combined88.3m shares/350mtermdebt. Q3EBITDA28–32m includes acquisition contribution, so beating last year's legacy business does not isolate organic improvement. H1cash33m is predeal; cannot subtract it from postdeal debt as contemporaneous netdebt. Q3guide midpoint30m versus7.1m Q2 is not a comparable organicgrowth rate. Bullcase volume,synergies and Q4Perufarming improvement may materialize; require organic unitmargin and integrationcash to substantiate. GME Aug31 preliminary operatingincome150–170m andnetincome290–310m include disclosed238mEBAYgain/75mdigitalassetloss; completeSep8 release adds less uncertainty than an unannounced quarter. Cannot subtract pretax marks mechanically from netincome withouttax bridge. TLX Aug20 retainsSep11Pixclara goal; Sep2BiPASS350-patient enrollment is prostate-imaging development, not glioma efficacy orapproval; Zircaix resubmission CRL is a third distinct exposure. Sources https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-announces-fiscal-2026-second-quarter-financial ; https://investor.gamestop.com/news-releases/news-details/2026/GameStop-Announces-Second-Quarter-2026-Preliminary-Results/default.aspx ; https://telixpharma.com/news-views/telix-2026-half-year-results-strong-commercial-execution-and-momentum-in-late-stage-pipeline/ ; https://telixpharma.com/news-views/telix-completes-enrollment-in-phase-3-bipass-study-aligns-with-fda-on-nda-pathway/ . Facts support prospective review, not price targets orpositive edge. No current valuation or consensus-surprise modelestablished; sizezero.

Premises:1.May18 2022issuerprospectus sought close-to-open equityexposure usingsecurities/ETFs,derivativesandTreasurycollateral;0.55%annualmanagementfee explicitlyexcluded transaction/derivativecosts.2.July14 2023boardsupplementsetsJuly31lasttrading andexpectedon/aboutAug10liquidation;notJuly19 (observation5790corrected5792).3.Wrapperavailability andeconomicviabilitymustbecheckedbeforeusingoldresearchasinvestmentinstructions. Conclusion:noNSPY/NIWMentryfromhistoricalprospectus. Fees accrue toprovider; transactioncosts tointermediaries; investorkeepsthenetreturn. Counterexample: closurecanreflectpoorcommercialscale ratherthanabsenceofanomaly;liquidationnoticeisnotstandalonecausalproof. OurcostedETFtestsuppliesaseparateproxyrejection. Cashcollateralinterest,futuresbasisandrollmeanETFcashstocknighttestisnotexactfundNAVreplication. Currentproductsharevaluationnotapplicabletohistoricallyliquidatedfunds. Sources https://www.sec.gov/Archives/edgar/data/1199046/000158064222002817/unifiedseriestrust_497.htm ; https://www.sec.gov/Archives/edgar/data/1199046/000158064223003676/nightshares497s.htm .

Premises:1.SMH Feb1 2026 statutory prospectus identifies third-party/raw-material dependence,highcapex,cyclical pricing and25-name index;scarce chips canliftpriceswhilefoundry/materialcostsandnewcapacityhurtotherholdings.2.XLISep3issuerweightsGEV4.62%+ETN2.81%=7.43%;notunaffectedbenchmarkforourpower-equipmentwatch.3.IYTSep3marine2%,rail31.57%,airlines14.87%:notbroadtankerfreightproxy. Conclusionvalid:theseETFs provide predefined cross-sector execution controls,notcausal estimates or new physical-bottleneck trades. Soundnesslimits:datedcurrentweightsnotbackcast,andissuerdisclosuresbroadratherthanneworderbookevidence. Counterexample:anETFcanprofitfromscarcityifnetconstituentrentpositive;that requiresdatedcomponent-levelcashtransmission,notitssectorname. StartstateN0completedprospectiveincidents;goalindependentprofitableeventpayoff;bindingconstraintidentificationandrealisticexecution,notabilitytobuyETF. Source https://www.sec.gov/Archives/edgar/data/1137360/000113736026000117/vanecksemiconductoretfsmh4.htm ; https://www.ssga.com/us/en/individual/etfs/state-street-industrial-select-sector-spdr-etf-xli ; https://www.ishares.com/us/products/239501/ishares-u-s-transportation-etf . Observations5793–5795 dateperiods andorigins;noETF10K,readstatutoryprospectusrisksection.

This is implementation unit economics, not token intrinsic valuation. Premise1 venue fee table https://docs.alpaca.markets/us/docs/crypto-fees lists25bp base taker fee and15bp maker, fee on creditedasset. Premise2 assume10bp slippage eachside; not measured executablequote. Vectorbt cash-fee convention yields flat roundtrip multiplier(1-.001)(1-.0025)/[(1+.001)(1+.0025)]=.9930244319, loss.69756%; grossprice rise.70246% breaks even. Twenty sequential full-notional flatprice roundtrips lose13.0642%, showing rate and compoundedtotal; frequency is scenario not monthlyforecast. Counterexample: passive fills could lower fee but maker eligibility, adverse selection and fills unmeasured, so cannot substitute15bp without testing. Venue/liquidityproviders benefit from turnover regardlessfundedge. $349.01 target gap equals147.97%of235.86fundcash, not a plausible target assumption or source of alpha. Fees known; slippage/frequency hypothetical; token valuation/protocolcashflow outside tonight's quantifiedtest. Binding constraint is validated net expectancy, not bookcap.

Premises:1 XLF owns sector equities, so an inexpensive ETF valuation is not independently an inexpensive option;2 trailing distribution yield is an approximation for option carry, not a confirmed cash dividend;3 issuerNAV andstockquote comparisons need same date. Sep3 issuer76holdings,forwardPE16.32,PB2.48,distributionyield1.38%,expense.08% annual,NAV58.54,AUM55.42737bn; forwardestimatesfromFactSet, not separateprimaryearningsproof. Source https://www.ssga.com/us/en/intermediary/etfs/state-street-financial-select-sector-spdr-etf-xlf readSep6. Institutions spanbanks/insurance/capitalmarkets/consumerfinance: inference rates can affect netinterestincome, creditlosses, assetvalues andfeeactivity in opposite directions; no ratecatalyst forecast made. Expense rate .0008 implies ~.00001587 over5/252year and~$881.39 annual on hypothetical1.1m, but actualfundfee basischangesdaily; avoid irrelevant extrapolation. For account127.65 annual expense exposure at constantbalance would .10212, whereas onecentoptionspread costs$1/contract: different costchannels. We useq=.0138 as sensitivity input, r=.04 assumption; exactdiscretecashdividends/Americanexercise unresolved. Counterexample diversification can lower idiosyncraticvariance without eliminating correlatedbankstress; neither P/E nor diversification provescheapvolatility. No moneyallocated.

Premises: May11 issuer Q3 endedMar31 reports organic sales-6% from volume/mix-11points and pricing+5, adjustedEBITDA26m versus34m, CFO38m andFCF35m; debt549m/net505m. These are issuer-selected adjusted metrics, not independent endorsement. Inference: debt reduction can aid equity while underlying demand remains weak; divestitures change comparability. Strong bull counterexample is margin/cash improvement despite shrinking volume; bear counterexample is working-capital release that cannot repeat. Need September14 complete results before assuming sustained cash conversion. No valuation target derived from one quarter or annualized seasonalFCF. Primary source https://ir.hain.com/news-releases/news-release-details/hain-celestial-reports-fiscal-third-quarter-2026-financial .

Numberedpremises:1.BSIN(formerUSEG)Apr27five-year100%takeorpayat285USD/Mcf,capacity14.4MMcf/year=>4.104mUSDyear/.342mmonthgrossplantgaterevenueifdelivered;buyerbearsdownstreamcosts.2.Aug11issuerH1cashG&A/Q2runrate1.8mquarter=>7.2mannualized;heliumcapacitygrossrevenuecovers57%beforeplantcosts. Otheroil/CO2incomeandfuturecostreductionsmeanthisisnotstandaloneinsolvencyproof. H1equityproceeds17.189m,OCF-3.315m;cashincreasefinanced.3.ASPIJune23contract>600USD/Mcffor15%planned70Mcf/day;at600full-yearfullcapacityhelium15.33m,thecontracted15%portion2.2995mminimumpriceillustration. Aug20commissioningandSeptemberfirstshipmentexpectationarenotactualacceptedshipments;85%uncontractedasofthatnotice.4.ASPIQ2Helium/LNGsegment654krev/-5.987mnetbeforeNCIcurrentlyLNG;groupcash219.596mandshortterminvestments35.3moffsetby39.973mH1continuingOCFuseandotherbusinesscommitments. Conclusionvalid:contractsallocatecostriskandshowupstreampricingpower,butneithernameyetprovidesverifiedsteadyheliumfreecashfloworstockedge. Soundnesslimits:undisclosedplantcosts,counterparties,qualityacceptanceandconstructiontiming;285vs>600notcleanapples-to-applespriceindex. Fiscal-yearadjustedguidevaluationAPD22.41x/LIN26.82xatSep4pricesdoesnotisolateheliumfairvalue. Strongcountercase:smallproducers'offtakecansecurenewcapitalandnewcashflowtransformsbase;answerrequireactualdelivery/plantmarginandpostfinancingper-sharevalue. Currentproposal0,ASPIpublicCMDmonitor43Sept8notentry. Sources https://www.sec.gov/Archives/edgar/data/101594/000143774926013368/ex_950842.htm ; https://ir.bigskyindustrialinc.com/news-releases/news-release-details/big-sky-industrial-inc-reports-second-quarter-2026-results-and ; https://www.sec.gov/Archives/edgar/data/1921865/000147793226003952/aspi_ex991.htm ; https://www.sec.gov/Archives/edgar/data/1921865/000119312526352603/aspi-20260630.htm .

Premises: 1.Fixed61.25cash remains contingent onclosing;July31issuer expectsH12027. 2.July17executedwaiver halvesparentterminationfee350mto175m andwaivesenddateterminationuntilMay31 2027;thispaymentgoestocompany,notdirectholderfloor.3.Sep2offeringclosed7,079,646shares,396mnet,for400mloanrepayment;8mPIPEshareswereunwound,so replacementissuancealoneisnot7.08mnetnewsharesrelativeoriginalfundingstate.4.July2NMPRCvoidedPIPEbutdidnotrejectmergerorrequireimmediaterefiling;costscannotfallonratepayerswithoutfutureauthorization.Aug27orderallowsnarrowrefinancing,notmerger. Conclusion: strong evidence of procedural/financingprogress coexists with unresolvedmerits andweakerfeeprotection. No calibratedsuccessprobability. Counterexampletofailurecertainty: regulatorsleftapplicationalive; counterexampletoclosingcertainty: priorAvangriddealterminatedafterNMPRCdenial despiteotherapprovals. Soundness: signedwaiverandregulatorordersstrong;futurebreakvalueandtimingassumptionsweak. Validity: this supportswatchandzerosize,notclaimthatthedealwillfail. Sources https://www.sec.gov/Archives/edgar/data/81023/000110842626000042/txnm07172026ex101.htm ; https://www.sec.gov/Archives/edgar/data/1108426/000110842626000058/pnm-20260902.htm ; https://www.txnmenergy.com/~/media/Files/P/PNM-Resources/rates-and-filings/2025%20Blackstone%20Infrastructure/PNM/FINAL%20ORDER%20ON%20SHOW%20CAUSE%20PROCEEDING.pdf ; https://www.sec.gov/Archives/edgar/data/1634997/000119312524000160/d677779dex991.htm .

Premises: split changes per-unit quotations rather than enterprise cash generation; one-off merger receipts must be separated from recurring operations; operating facts alone cannot specify nextweekreturntails. IssuerOCT30 2025sayssplitintendedtoimproveemployeeoptionaccessibility. ClearingmechanicsconfirmedOCC57651. Q2letterJuly16 2026reportsrevenue~12.6bn,+13%year,margin33.4%vs34.1%,FCF1.525bnvs2.267bn; companyattributespartoftaxpaymentincreasetoWBDfee. FYforecastrevenue51.0–51.4bn,margin31.5%,FCF12.5bn remainsforwardlooking. 10QreportsFeb27mergerterminationand2.8bnreceiptinQ1otherincome,relatedfinancingterminatedwithnothingborrowed. Jun30cash/restrictedcash/STinvestments9.131bnversusdebt14.309bn: profitablelargecashgeneratorwithnetdebt, notfreecashguarantee. Strongestcounterargument: slowinggrowthandcashdeclinecouldsupportputs; resolutiongrowthandcash-use/tax-timingcanbothbetrue,butnoprobabilityforSept11strike72follows. OthercounterargumentpositivevariancejumponFeb27 shouldnotbeconvertedmechanicallyintonegative-tailprobability. Collectedissuerfilingandletter, sameeconomicorigin; OCCindependentclearingorigin; noindependentcustomerpopulationstudied, notneededforcorporateactionproof. Fundamentalearningsmultipleorunit-marginforecastwouldnotresolvebindingexecutableoptiondataandpayoffgaps, so no inventedvaluationtarget. Sources https://ir.netflix.net/investor-news-and-events/financial-releases/press-release-details/2025/Netflix-Announces-Ten-For-One-Stock-Split/default.aspx ; https://infomemo.theocc.com/infomemos?number=57651 ; https://www.sec.gov/Archives/edgar/data/1065280/000106528026000211/ex991_q226.htm ; https://www.sec.gov/Archives/edgar/data/1065280/000106528026000212/nflx-20260630.htm . NoSeptemberdatedcatalystestablished; existingpostholidaymonitor30suffices.

Premises: 1) Sponsor's Aug21 update removes the original plant; no alternate-site approval independently recovered. 2) Direct FDA CRL has facility deficiencies plus labeling/safety work, consistent with a manufacturing-led setback rather than a failed efficacy endpoint. 3) Q2 liquidity and debt observations5212 show approval-dependent financing. Derived static burn25.40m/month; gross liquidity19.37months, or14.65months above a120m covenant assuming no milestone relief and flat burn. Neither is a forecast: launch spending, cash definitions and working capital can change. H1 ATM160.774m exceeded operating burn152.408m. Approximate basic equity6.735bn atSep4IEX55.305; adding disclosed prefunded equivalents gives7.319bn before options/RSUs, using differently dated share counts. Cash292.088m net of principal is not a valuation floor. Conclusion: watch, no numerical approval or run-up edge. Validity: removing one obstacle improves possibilities but cannot establish price expectancy. Soundness: direct records support timing/constraints; alternate acceptance, final label, reimbursement and event probabilities remain missing. Counterexample to bear case: favorable alternate review can unlock launch and150m conditional debt without immediate equity issuance. Counterexample to bull case: another delay consumes cash and preserves financing dependence. Sources https://www.sec.gov/Archives/edgar/data/1727196/000119312526336732/srrk-20260630.htm ; https://download.open.fda.gov/crl/CRL_BLA761463_20250922.pdf ; https://scholarrock.gcs-web.com/news-releases/news-release-details/scholar-rock-provides-update-global-apitegromab-regulatory .

Premises: (1) QatarEnergy March24 RNS establishes damaged LNG infrastructure and reduced helium output, not September production quantity. (2) LIN Q1 issuer transcript says85–90%contracted;Q2July31CFO reportspositiveheliumdollarcontributionbutdislocationcosts dilutepercentage margin,whileheliumguidanceunchanged. (3) APDQ2April30slides ~90%contracted3–5years,primarilyUSsources,cavernand~500ISOcontainers,FY25heliumsalesHSD%;July30Q3bridgehelium-$0.07EPSdespitepositiveelectronicsvolume,annualheadwind~3%. (4) AirLiquideJuly28H1sourceinterruptionhurtmerchantvolumes;EMEA+0.2%vs+1.9%excludinghelium. Conclusionvalid:physicalscarcitydoesnotuniformlybenefitdistributors;LINhasqualitativecurrentpositivecapture,APDhasreliability/contractgrowthbutnegativeYoYheliumbridge,AirLiquidehasvolumeexposure. DoNOTequatemargin%dilutionwithlostprofit,norAPDnegativeYoYwithnegativeabsoluteheliumprofit. Soundness:issuerdisclosurebiasandmissingheliumEBITdollars/contractrepricingschedules preventvaluationedge. Counterexamples:priceescalatorscanworkdespitecontractterms;newcostlyreplacementvolumecanraiserevenueanddilutemarginwhileaddingcashprofit;volumegrowthcanoffsetlowerrealizedprices. Sources: https://assets.linde.com/-/media/global/corporate/corporate/documents/investors/quarterly-earnings/investor-call-transcript-2q26.pdf ; https://investors.airproducts.com/static-files/873bd766-037f-459f-8a09-ac5bff2165b1 ; https://www.airliquide.com/sites/airliquide.com/files/2026-07/air-liquide-pr-h1-with-an-acceleration-in-the-second-quarter-air-liquide-combines-growth-with-continuous-performance-improvement.pdf . Detailedoriginsobs5198–5210. Startstateconcentratedsupply/interruptedlogistics;goalstatepositiveincrementalFCFandvalidatedstockpayoff;bindingconstraintrepricingnetofreplacementcostsanddeliveredvolume. Businesswatchonly,notbuy.

Premises: 1. MUFY2025filingdetailslimited/solesourcesandqualificationdelays despitegenerallymultiplematerials suppliers;June24Q3results showstrongprofitability butnotSeptemberincrementalallocation. 2. MPFY2025filingdatescessationofChinasalestoJuly2025 andspecifiesmagnetvolume/quality obligations;August6Q2records840tNdPrproduction,1006tsales,revenue108.5m and17.6mseparatepricesupport,adjustednetloss2.1m. Conclusionvalid:beneficiariesofscarcitycanstillbeconstrainedbyinputs,rampandcontractterms. RejectassumptionthatMPsupportincomeequalsproductsalesorthatoldShengheconcentrationcontinuesunchanged. Who benefits:qualifiedmemory/materialproducersandtheirlimitedqualifiedsuppliers;customersbearhighercostandmayredesign/re-source,whichcanlatereroderents. Counterexample:morephysicaloutputunprofitableafterqualification/capex;positivecurrentmarginsnormalizewithnewcapacity. Neithernamehasindependentlyvalidatednetexitpayoffs;MUalonehascurrentSMAcrossbut0wholeaffordableunder212.75capandfractionalexitsuntested;MPcrossfalse. Sources https://www.sec.gov/Archives/edgar/data/723125/000072312525000028/mu-20250828.htm ; https://investors.micron.com/financials/quarterly-results/ ; https://www.sec.gov/Archives/edgar/data/1801368/000180136826000008/mp-20251231.htm ; https://investors.mpmaterials.com/investor-news/news-details/2026/MP-Materials-Reports-Second-Quarter-2026-Results/default.aspx .